Ronald Klein1, Barbara E K Klein. 1. Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Abstract
PURPOSE: To examine prevalence of five age-related eye conditions (age-related cataract, AMD, open-angle glaucoma, diabetic retinopathy [DR], and visual impairment) in the United States. METHODS: Review of published scientific articles and unpublished research findings. RESULTS: Cataract, AMD, open-angle glaucoma, DR, and visual impairment prevalences are high in four different studies of these conditions, especially in people over 75 years of age. There are disparities among racial/ethnic groups with higher age-specific prevalence of DR, open-angle glaucoma, and visual impairment in Hispanics and blacks compared with whites, higher prevalence of age-related cataract in whites compared with blacks, and higher prevalence of late AMD in whites compared with Hispanics and blacks. The estimates are based on old data and do not reflect recent changes in the distribution of age and race/ethnicity in the United States population. There are no epidemiologic estimates of prevalence for many visually-impairing conditions. CONCLUSIONS: Ongoing prevalence surveys designed to provide reliable estimates of visual impairment, AMD, age-related cataract, open-angle glaucoma, and DR are needed. It is important to collect objective data on these and other conditions that affect vision and quality of life in order to plan for health care needs and identify areas for further research.
PURPOSE: To examine prevalence of five age-related eye conditions (age-related cataract, AMD, open-angle glaucoma, diabetic retinopathy [DR], and visual impairment) in the United States. METHODS: Review of published scientific articles and unpublished research findings. RESULTS:Cataract, AMD, open-angle glaucoma, DR, and visual impairment prevalences are high in four different studies of these conditions, especially in people over 75 years of age. There are disparities among racial/ethnic groups with higher age-specific prevalence of DR, open-angle glaucoma, and visual impairment in Hispanics and blacks compared with whites, higher prevalence of age-related cataract in whites compared with blacks, and higher prevalence of late AMD in whites compared with Hispanics and blacks. The estimates are based on old data and do not reflect recent changes in the distribution of age and race/ethnicity in the United States population. There are no epidemiologic estimates of prevalence for many visually-impairing conditions. CONCLUSIONS: Ongoing prevalence surveys designed to provide reliable estimates of visual impairment, AMD, age-related cataract, open-angle glaucoma, and DR are needed. It is important to collect objective data on these and other conditions that affect vision and quality of life in order to plan for health care needs and identify areas for further research.
Authors: David S Friedman; Roger C W Wolfs; Benita J O'Colmain; Barbara E Klein; Hugh R Taylor; Shelia West; M Cristina Leske; Paul Mitchell; Nathan Congdon; John Kempen Journal: Arch Ophthalmol Date: 2004-04
Authors: John H Kempen; Paul Mitchell; Kristine E Lee; James M Tielsch; Aimee T Broman; Hugh R Taylor; M Kamran Ikram; Nathan G Congdon; Benita J O'Colmain Journal: Arch Ophthalmol Date: 2004-04
Authors: Nathan Congdon; Benita O'Colmain; Caroline C W Klaver; Ronald Klein; Beatriz Muñoz; David S Friedman; John Kempen; Hugh R Taylor; Paul Mitchell Journal: Arch Ophthalmol Date: 2004-04
Authors: Nathan Congdon; Johannes R Vingerling; Barbara E K Klein; Sheila West; David S Friedman; John Kempen; Benita O'Colmain; Suh-Yuh Wu; Hugh R Taylor Journal: Arch Ophthalmol Date: 2004-04
Authors: John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard F Hamman Journal: Arch Ophthalmol Date: 2004-04
Authors: David S Friedman; Benita J O'Colmain; Beatriz Muñoz; Sandra C Tomany; Cathy McCarty; Paulus T V M de Jong; Barbara Nemesure; Paul Mitchell; John Kempen Journal: Arch Ophthalmol Date: 2004-04
Authors: Rohit Varma; Sylvia H Paz; Stanley P Azen; Ronald Klein; Denise Globe; Mina Torres; Chrisandra Shufelt; Susan Preston-Martin Journal: Ophthalmology Date: 2004-06 Impact factor: 12.079
Authors: Stephanie J Loomis; Alison P Klein; Kristine E Lee; Fei Chen; Samantha Bomotti; Barbara Truitt; Sudha K Iyengar; Ronald Klein; Barbara E K Klein; Priya Duggal Journal: Ophthalmic Epidemiol Date: 2017-11-28 Impact factor: 1.648
Authors: Dean A VanNasdale; Ann E Elsner; Todd D Peabody; Kimberly D Kohne; Victor E Malinovsky; Bryan P Haggerty; Anke Weber; Christopher A Clark; Stephen A Burns Journal: Invest Ophthalmol Vis Sci Date: 2014-12-18 Impact factor: 4.799
Authors: Simon Kaja; Andrew J Payne; Yuliya Naumchuk; Deborah Levy; Danish H Zaidi; Alexa M Altman; Saba Nawazish; Jasleen K Ghuman; Bryan C Gerdes; Mark A Moore; Peter Koulen Journal: Exp Eye Res Date: 2015-06-03 Impact factor: 3.467
Authors: Arthika Chandramohan; Sandra S Stinnett; John T Petrowski; Stefanie G Schuman; Cynthia A Toth; Scott W Cousins; Eleonora M Lad Journal: Retina Date: 2016-05 Impact factor: 4.256
Authors: Ethan G Jaffee; Vineet M Arora; Madeleine I Matthiesen; Seenu M Hariprasad; David O Meltzer; Valerie G Press Journal: J Health Commun Date: 2016-09-23